Cargando…
ADAM9 Expression Is Associate with Glioma Tumor Grade and Histological Type, and Acts as a Prognostic Factor in Lower-Grade Gliomas
The A disintegrin and metalloproteinase 9 (ADAM9) protein has been suggested to promote carcinoma invasion and appears to be overexpressed in various human cancers. However, its role has rarely been investigated in gliomas and, thus, in the current study we have evaluated ADAM9 expression in gliomas...
Autores principales: | Fan, Xing, Wang, Yongheng, Zhang, Chuanbao, Liu, Li, Yang, Sen, Wang, Yinyan, Liu, Xing, Qian, Zenghui, Fang, Shengyu, Qiao, Hui, Jiang, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037653/ https://www.ncbi.nlm.nih.gov/pubmed/27571068 http://dx.doi.org/10.3390/ijms17091276 |
Ejemplares similares
-
Radiogenomics of lower-grade gliomas: a radiomic signature as a biological surrogate for survival prediction
por: Qian, Zenghui, et al.
Publicado: (2018) -
MRI features predict p53 status in lower-grade gliomas via a machine-learning approach
por: Li, Yiming, et al.
Publicado: (2017) -
IDH mutation-specific radiomic signature in lower-grade gliomas
por: Liu, Xing, et al.
Publicado: (2019) -
A radiomic signature as a non-invasive predictor of progression-free survival in patients with lower-grade gliomas
por: Liu, Xing, et al.
Publicado: (2018) -
Combination genetic signature stratifies lower-grade gliomas better than histological grade
por: Chan, Aden Ka-Yin, et al.
Publicado: (2015)